Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a... see more

TSX:KSI - Post Discussion

Kneat.com Inc > 2 Linkedin posts
View:
Post by Possibleidiot01 on Jul 03, 2024 7:23pm

2 Linkedin posts

Kneat Solutions 9,553 followers
 
 
Discover how a Top-20 Japanese multinational pharmaceutical company is revolutionizing its validation processes with Kneat's cutting-edge digital technology.

By leveraging Kneat Gx, they have enhanced global operational efficiencies, data integrity, and auditability. Key benefits include:

Reduced time and effort in validation protocol generation and execution

Simplified protocol creation with fewer copy/paste efforts using Kneat Gx’s properties and Tag ID management

Improved audit experiences thanks to easy document navigation and quick access to raw data

Enhanced standardization and collaboration across global sites with Kneat Gx’s common platform and libraries

Hear directly from our customer: "Kneat Gx is better for our well-being, better for the planet, and more cost-effective."

Read the full case study to see how your organization can achieve similar results! https://hubs.li/Q02DH8Td0

hashtagPharmaceutical hashtagDigitalTransformation hashtagOperationalEfficiency hashtagDataIntegrity hashtag


 
 
Cell and Gene Therapy Catapult is Kneat’s newest customer in this exciting field! Cell and Gene Therapy Catapult was established as an independent center of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialization. This UK- based company will leverage Kneat’s leading digital validation services to provide fast, compliant validation solutions in house and across their customer base.

We’re so excited to work with Catapult on providing revolutionary therapies to the world!

To learn why Life Science leaders like Catapult trust Kneat, sign up for our demo webinar, register now! https://hubs.li/Q02DGCL00

hashtagKneatGx hashtagCatapult hashtagNewCustomer hashtagGeneTherapy hashtagDigital hashtagValidation

 

 


Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities